2 July 2020 - Governments are pouring money into a more urgent version of the space race.

By Oxford’s eastern bypass road, some way from the famous spires, sits an unremarkable collection of glass office buildings that includes the Jenner Institute. Described by an industry observer as “a slightly dusty corner” of the university, until six months ago it mostly busied itself with useful but ill-funded research into diseases suffered by people in poor countries. Now it has become the likeliest candidate to produce the world’s first vaccine against COVID-19.

Read The Economist article